Cathelijne Dickhoff
Wehe-den Hoorn, GR, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Identifying Predictors for Heart Failure Outcomes in Phospholamban p.(Arg14del)-Positive Individuals.
Journal: JACC. Heart failure
Published: February 21, 2025
Age-related penetrance of phospholamban p.Arg14del cardiomyopathy.
Journal: European journal of heart failure
Published: September 25, 2024
ECG-only explainable deep learning algorithm predicts the risk for malignant ventricular arrhythmia in phospholamban cardiomyopathy.
Journal: Heart rhythm
Published: February 15, 2024
Long-term reliability of the phospholamban (PLN) p.(Arg14del) risk model in predicting major ventricular arrhythmia: a landmark study.
Journal: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
Published: December 11, 2023
Outpatient treatment of worsening heart failure with intravenous diuretics: first results from a multicentre 2-year experience.
Journal: ESC heart failure
Published: October 04, 2021
Prediction of ventricular arrhythmia in phospholamban p.Arg14del mutation carriers-reaching the frontiers of individual risk prediction.
Journal: European heart journal
Published: November 17, 2020
Outpatient treatment of worsening heart failure with intravenous and subcutaneous diuretics: a systematic review of the literature.
Journal: ESC heart failure
Published: June 14, 2019
N-Terminal Pro-B-Type Natriuretic Peptide (NT-proBNP) Measurements Until a 30% Reduction Is Attained During Acute Decompensated Heart Failure Admissions and Comparison With Discharge NT-proBNP Levels: Implications for In-Hospital Guidance of Treatment.
Journal: Journal of cardiac failure
Published: November 26, 2014
Rationale and design of PRIMA II: A multicenter, randomized clinical trial to study the impact of in-hospital guidance for acute decompensated heart failure treatment by a predefined NT-PRoBNP target on the reduction of readmIssion and Mortality rAtes.
Journal: American heart journal
Published: September 17, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026